Study: Afirma Genomic Test Can Reduce Unnecessary Fine Needle Aspiration Biopsies in Thyroid Cancer February 29, 2016Vol.39 No.02
Gilotrif Improves PFS Compared to Iressa in Phase IIb Trial in Non-Small Cell Lung Cancer February 29, 2016Vol.39 No.02
Two Studies Evaluate 2nd Line Pancreatic Cancer Treatments Following Abraxane February 29, 2016Vol.39 No.02
OBI-822/821 Phase II/III Study Does Not Meet PFS Endpoint, But Shows Positive Results in Breast Cancer Patients with Immune Response February 29, 2016Vol.39 No.02
Drugs & Targets FDA Approves Gazyva Plus Bendamustine for Patients with Follicular Lymphoma February 29, 2016Vol.39 No.02
Halaven Study Improves Overall Survival In Liposarcomas and Leiomyosarcomas February 29, 2016Vol.39 No.02
Phase III Blincyto Study in Leukemia Stopped Early After Meeting OS Primary Endpoint February 29, 2016Vol.39 No.02
Drugs & Targets Opdivo-Yervoy Combination Granted Accelerated Approval in Metastatic Melanoma February 01, 2016Vol.39 No.01
Analysis Evaluates Moore Criteria for Bevacizumab Effectiveness in Cervical Cancer February 01, 2016Vol.39 No.01
